Three clinical studies give GSKâs cancer vaccine an edge

Source: EH News Bureau Author: Staff GlaxoSmithKline Pharmaceuticals Limited (GSK) recently shared the results of three recently published clinical studies, conducted for its cervical cancer vaccineâ€"Cervarix. Said Dr Hasit Joshipura, Vice President, South Asia and Managing Director, GSK India, “The findings confirmed that the vaccine offers protection against five of the most common cancer-causing virus types, generates [...]